This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Chr. Hansen Holding Crescita futura

Future criteri di controllo 2/6

Chr. Hansen Holding is forecast to grow earnings and revenue by 11.8% and 5.8% per annum respectively while EPS is expected to grow by 11.6% per annum.

Informazioni chiave

11.8%

Tasso di crescita degli utili

11.6%

Tasso di crescita dell'EPS

Chemicals crescita degli utili	51.6%
Tasso di crescita dei ricavi	5.8%
Rendimento futuro del capitale proprio	n/a
Copertura analitica	Good
Ultimo aggiornamento	31 May 2023

Aggiornamenti recenti sulla crescita futura

Recent updates

Previsioni di crescita degli utili e dei ricavi

BMV:CHR N - Stime future degli analisti e dati finanziari passati (EUR Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
8/31/2025	1,513	317	276	430	9
8/31/2024	1,419	286	244	396	11
8/31/2023	1,336	247	199	347	12
2/28/2023	1,294	229	133	276	N/A
11/30/2022	1,259	228	128	270	N/A
8/31/2022	1,218	225	167	309	N/A
5/31/2022	1,183	230	191	327	N/A
2/28/2022	1,146	221	228	354	N/A
11/30/2021	1,102	209	233	352	N/A
8/31/2021	1,077	199	155	311	N/A
5/31/2021	1,038	199	169	318	N/A
2/28/2021	1,014	213	208	358	N/A
11/30/2020	994	222	224	374	N/A
8/31/2020	970	232	246	365	N/A
5/31/2020	798	218	280	369	N/A
2/29/2020	844	221	223	326	N/A
11/30/2019	888	224	212	324	N/A
8/31/2019	937	229	180	299	N/A
5/31/2019	1,152	246	174	306	N/A
2/28/2019	1,132	240	190	313	N/A
11/30/2018	1,112	233	181	295	N/A
8/31/2018	1,097	228	195	302	N/A
5/31/2018	1,084	226	164	271	N/A
2/28/2018	1,080	224	168	270	N/A
11/30/2017	1,075	224	181	286	N/A
8/31/2017	1,063	224	178	284	N/A
5/31/2017	1,035	212	201	290	N/A
2/28/2017	1,007	205	174	260	N/A
11/30/2016	976	192	N/A	246	N/A
8/31/2016	949	184	N/A	245	N/A
5/31/2016	927	179	N/A	226	N/A
2/29/2016	905	174	N/A	237	N/A
11/30/2015	885	172	N/A	239	N/A
8/31/2015	859	163	N/A	222	N/A
5/31/2015	830	150	N/A	205	N/A
2/28/2015	800	141	N/A	188	N/A
11/30/2014	773	133	N/A	178	N/A
8/31/2014	756	132	N/A	176	N/A
5/31/2014	745	145	N/A	174	N/A
2/28/2014	738	142	N/A	182	N/A
11/30/2013	731	135	N/A	186	N/A
8/31/2013	738	138	N/A	190	N/A
5/31/2013	730	126	N/A	185	N/A
2/28/2013	719	125	N/A	175	N/A
11/30/2012	710	135	N/A	172	N/A
8/31/2012	699	129	N/A	175	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: CHR N's forecast earnings growth (11.8% per year) is above the savings rate (7.6%).

Guadagni vs Mercato: CHR N's earnings (11.8% per year) are forecast to grow faster than the MX market (9.2% per year).

Guadagni ad alta crescita: CHR N's earnings are forecast to grow, but not significantly.

Ricavi vs Mercato: CHR N's revenue (5.8% per year) is forecast to grow slower than the MX market (6.2% per year).

Ricavi ad alta crescita: CHR N's revenue (5.8% per year) is forecast to grow slower than 20% per year.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Insufficient data to determine if CHR N's Return on Equity is forecast to be high in 3 years time

This company is no longer active

Chr. Hansen Holding Crescita futura

Future criteri di controllo 2/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Chr. Hansen Holding A/S Revises Revenue Guidance for January 1, 2023 – December 31, 2023

Chr. Hansen Holding A/S Provides Earnings Guidance for the Period September 1, 2022 – August 31, 2023

Chr. Hansen Holding A/S Provides Revenue Guidance for 2022/23

Chr. Hansen Holding A/S Provides Earnings Guidance for the Full Year of Fiscal 2022

Recent updates

Chr. Hansen Holding A/S(CPSE:CHR) dropped from FTSE All-World Index (USD)

Chr. Hansen Holding A/S(CPSE:CHR) dropped from OMX Copenhagen 20 Index

Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S (CPSE:CHR).

Novozymes A/S (CPSE:NZYM B) completed the acquisition of Chr. Hansen Holding A/S (CPSE:CHR).

Chr. Hansen Holding A/S to Report Fiscal Year 2024 Results on Feb 06, 2025

Chr. Hansen Holding A/S Revises Revenue Guidance for January 1, 2023 – December 31, 2023

Novozymes A/S and Chr. Hansen Announce Executive Leadership Team and Organizational Structure

Chr. Hansen Holding A/S Provides Earnings Guidance for the Period September 1, 2022 – August 31, 2023

Executive VP recently bought Mex$1.5m worth of stock

First quarter 2023 earnings released: EPS: €0.38 (vs €0.35 in 1Q 2022)

Chr. Hansen Holding A/S Provides Revenue Guidance for 2022/23

Novozymes A/S (CPSE:NZYM B) agreed to acquire Chr. Hansen Holding A/S (CPSE:CHR).

Novozymes A/S (CPSE:NZYM B) agreed to acquire Chr. Hansen Holding A/S (CPSE:CHR).

Key Executive recently bought Mex$135k worth of stock

Chr. Hansen Holding A/S Approves Ordinary Dividend

Upcoming dividend of kr.7.04 per share

High number of new directors

Chr. Hansen Holding A/S to Report Q1, 2023 Results on Dec 12, 2022

Full year 2022 earnings released: EPS: €1.71 (vs €1.51 in FY 2021)

Chr. Hansen Holding A/S Proposes Ordinary Dividend for 2021/22

High number of new directors

Chr. Hansen Holding A/S to Report Q2, 2023 Results on Apr 13, 2023

Third quarter 2022 earnings released: EPS: €0.45 (vs €0.38 in 3Q 2021)

Chr. Hansen Holding A/S Provides Earnings Guidance for the Full Year of Fiscal 2022

High number of new directors

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita